Amelioration of water maze performance deficits by topiramate applied during pilocarpine-induced status epilepticus is negatively dose-dependent

Epilepsy Research

Volumn 73, Issue 2, 2007, Pages 173-180

  Frisch, Christian ^a   Kudin, Alexei P ^a   Elger, Christian E ^a   Kunz, Wolfram S ^a   Helmstaedter, Christoph ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Hippocampus; Pilocarpine; Status epilepticus; Topiramate; Water maze

Indexed keywords

DIAZEPAM; PILOCARPINE; TOPIRAMATE; WATER;

AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EPILEPTIC STATE; LEARNING; MALE; MAZE TEST; MEMORY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY;

ANIMALS; ANTICONVULSANTS; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; NEURONS; NEUROPROTECTIVE AGENTS; PILOCARPINE; RATS; RATS, WISTAR; STATUS EPILEPTICUS; SWIMMING; VIDEO RECORDING; WATER;

EID: 33847282506     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2006.10.001     Document Type: Article

References (64)

1. Abercombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94 (1946) 239-247
2. Alaverdashvili M., Kubova H., and Mares P. Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav. 7 (2005) 222-230
3. Arroyo S., Dodson W.E., Privitera M.D., Glauser T.A., Naritoku D.K., Dlugos D.J., Wang S., Schwabe S.K., and Twyman R.E. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol. Scand. 112 (2005) 214-222
4. Bailey K.R., and Mair R.G. Lesions of specific and nonspecific thalamic nuclei affect prefrontal cortex-dependent aspects of spatial working memory. Behav. Neurosci. 119 (2005) 410-419
5. Baldi E., Efoudebe M., Lorenzini C.A., and Bucherelli C. Spatial navigation in the Morris water maze: working and long lasting reference memories. Neurosci. Lett. 378 (2005) 176-180
6. Blumkin L., Lerman-Sagie T., Houri T., Gilad E., Nissenkorn A., Ginsberg M., and Watemberg N. Pediatric refractory partial status epilepticus responsive to topiramate. J. Child. Neurol. 20 (2005) 239-241
7. Borowicz K.K., Luszczki J.J., Duda A.M., and Czuczwar S.J. Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy. Epilepsia 44 (2003) 640-646
8. Boukhezra O., Riviello P., Fu D.D., Lui X., Zhao Q., Akman C., and Holmes G.L. Effect of the postictal state on visual-spatial memory in immature rats. Epilepsy Res. 55 (2003) 165-175
9. Cha B.H., Silveira D.C., Liu X., Hu Y., and Holmes G.L. Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res. 51 (2002) 217-232
10. D'Arcangelo G., Tancredi V., and Avoli M. Intrinsic optical signals and electrographic seizures in the rat limbic system. Neurobiol. Dis. 8 (2001) 993-1005
11. de Kloet E.R., Joels M., and Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6 (2005) 463-475
12. Detour J., Schroeder H., Desor D., and Nehlig A. A 5-month period of epilepsy impairs spatial memory, decreases anxiety, but spares object recognition in the lithium-pilocarpine model in adult rats. Epilepsia 46 (2005) 499-508
13. Easterling D.E., Zakszewski T., Moyer M.D., Margul B.L., Marriott T.B., and Nayak R.K. Plasma concentrations of topiramate, a new anticonvulsant in humans. Epilepsia 29 Suppl. (1988) 662
14. Ehninger D., and Kempermann G. Paradoxical effects of learning the Morris water maze on adult hippocampal neurogenesis in mice may be explained by a combination of stress and physical activity. Genes Brain. Behav. 5 (2006) 29-39
15. Faverjon S., Silveira D.C., Fu D.D., Cha B.H., Akman C., Hu Y., and Holmes G.L. Beneficial effects of enriched environment following status epilepticus in immature rats. Neurology 12 (2002) 1356-1364
16. Fisher A., Wang X., Cock H.R., Thom M., Patsalos P.N., and Walker M.C. Synergism between topiramate and budipine in refractory status epilepticus in the rat. Epilepsia 45 (2004) 1300-1307
17. Freitas R.M., Vasconcelos S.M., Souza F.C., Viana G.S., and Fonteles M.M. Monoamine levels after pilocarpine-induced status epilepticus in hippocampus and frontal cortex of Wistar rats. Neurosci. Lett. 370 (2004) 196-200
18. Fritz N., Glogau S., Hoffmann J., Rademacher M., Elger C.E., and Helmstaedter C. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav. 6 (2005) 373-381
19. Galani R., Weiss I., Cassel J.C., and Kelche C. Spatial memory, habituation, and reactions to spatial and nonspatial changes in rats with selective lesions of the hippocampus, the entorhinal cortex or the subiculum. Behav. Brain Res. 96 (1998) 1-12
20. Granon S., and Poucet B. Medial prefrontal lesions in the rat and spatial navigation: evidence for impaired planning. Behav. Neurosci. 109 (1995) 474-484
21. Hort J., Brozek G., Mares P., Langmeier M., and Komarek V. Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia 40 (1999) 1177-1183
22. Holmes G.L., Khazipov R., and Ben-Ari Y. Seizure-induced damage in the developing human: relevance of experimental models. Prog. Brain Res. 135 (2002) 321-334
23. Jahromi S.S., Pelletier M.R., McDonald P.J., Khosravani H., and Carlen P.L. Antiepileptic efficacy of topiramate: assessment in two in vitro seizure models. Brain Res. 872 (2000) 20-28
24. Johnstone S., and Rolls E.T. Delay, discriminatory, and modality specific neurons in striatum and pallidum during short-term memory tasks. Brain Res. 522 (1990) 147-151
25. Kalviainen R., Eriksson K., and Parvainen I. Refractory generalised convulsive status epilepticus: a guide to treatment. CNS Drugs 19 (2005) 759-768
26. Kavushansky A., Vouimba R.M., Cohen H., and Richter-Levin G. Activity and plasticity in the CA1, the dentate gyrus, and the amygdala following controllable vs. uncontrollable water stress. Hippocampus 16 (2006) 35-42
27. Kockelmann E., Elger C.E., and Helmstaedter C. Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res. 54 (2003) 171-178
28. Koh S., and Jensen F.E. Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann. Neurol. 50 (2001) 366-372
29. Kubova H., Mares P., Suchomelova L., Brozek G., Druga R., and Pitkanen A. Status epilepticus in immature rats leads to behavioural and cognitive impairment and epileptogenesis. Eur. J. Neurosci. 19 (2004) 3255-3265
30. Kudin A.P., Debska-Vielhaber G., Vielhaber S., Elger C.E., and Kunz W.S. The mechanism of neuroprotection by topiramate in an animal model of temporal lobe epilepsy. Epilepsia 45 (2004) 1478-1487
31. Lehmann O., Jeltsch H., Lazarus C., Tritschler L., Bertrand F., and Cassel J.C. Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study. Pharmacol. Biochem. Behav. 72 (2002) 899-912
32. Lee S.R., Kim S.P., and Kim J.E. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci. Lett. 281 (2000) 183-186
33. Liu Z., Gatt A., Mikati M., and Holmes G.L. Long-term behavioral deficits following pilocarpine seizures in immature rats. Epilepsy Res. 19 (1994) 191-204
34. Liu X., Muller R.U., Huang L.T., Kubie J.L., Rotenberg A., Rivard B., Cilio M.R., and Holmes G.L. Seizure-induced changes in place cell physiology: relationship to spatial memory. J. Neurosci. 23 (2003) 11505-11515
35. Löscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 50 (2002) 105-123
36. Miyoshi E., Wietzikoski S., Camplessei M., Silveira R., Takahashi R.N., and Da Cunha C. Impaired learning in a spatial working memory version and in a cued version of the water maze in rats with MPTP-induced mesencephalic dopaminergic lesions. Brain Res. Bull. 58 (2002) 41-47
37. Morris R.G., Garrud P., Rawlins J.N., and O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 297 (1982) 681-683
38. Mula M., Trimble M.R., and Sander J.W. The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia 44 (2003) 1573-1577
39. Niebauer M., and Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res. 837 (1999) 263-269
40. Niessen H.G., Angenstein F., Vielhaber S., Frisch C., Kudin A., Elger C.E., Heinze H.J., Scheich H., and Kunz W.S. Volumetric magnetic resonance imaging of functionally relevant structural alterations in chronic epilepsy after pilocarpine-induced status epilepticus in rats. Epilepsia 46 (2005) 1021-1026
41. Okada M., Yoshida S., Zhu G., Hirose S., and Kaneko S. Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca(2+)-induced Ca(2+)-releasing systems. Neuroscience 134 (2005) 233-246
42. Pitkanen A., and Kubova H. Antiepileptic drugs in neuroprotection. Expert Opin. Pharmacother. 5 (2004) 777-798
43. Pothuizen H.H., Zhang W.N., Jongen-Relo A.L., Feldon J., and Yee B.K. Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur. J. Neurosci. 19 (2004) 705-712
44. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 281-294
45. Reife R., Pledger G., and Wu S.C. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia 41 (2000) S66-S71
46. Rice A.C., Floyd C.L., Lyeth B.G., Hamm R.J., and DeLorenzo R.J. Status epilepticus causes long-term NMDA receptor-dependent behavioral changes and cognitive deficits. Epilepsia 39 (1998) 1148-1157
47. Rigoulot M.A., Koning E., Ferrandon A., and Nehlig A. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy. J. Pharmacol. Exp. Ther. 308 (2004) 787-795
48. Rigoulot M.A., Leroy C., Koning E., Ferrandon A., and Nehlig A. Prolonged low-dose caffeine exposure protects against hippocampal damage but not against the occurrence of epilepsy in the lithium-pilocarpine model in the rat. Epilepsia 44 (2003) 529-535
49. Schmidt-Kastner R., Heim C., and Sontag K.H. Damage of substantia nigra pars reticulata during pilocarpine-induced status epilepticus in the rat: immunohistochemical study of neurons, astrocytes and serum-protein extravasation. Exp. Brain Res. 86 (1991) 125-140
50. Schmidt-Kastner R., Tomac A., Hoffer B., Bektesh S., Rosenzweig B., and Olson L. Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats. Brain Res. Mol. Brain Res. 26 (1994) 325-330
51. Shank R.P., Doose D.R., Streeter A.J., and Bialer M.B. Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase. Epilepsy Res. 63 (2005) 103-112
52. Shank R.P., Gardocki J.E., Streeter A.J., and Maryanoff B.E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41 Suppl. 1 (2000) S3-S9
53. Shannon H.E., and Love P.L. Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats. Epilepsy Behav. 5 (2004) 857-865
54. Sills G.J., Butler E., Forrest G., Ratnaraj N., Patsalos P.N., and Brodie M. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 44 (2003) 886-892
55. Silva A.J., Giese K.P., Fedorov N.B., Frankland P.W., and Kogan J.H. Molecular, cellular, and neuroanatomical substrates of place learning. Neurobiol. Learn. Mem. 70 (1998) 44-61
56. Stewart L.S., and Persinger M.A. Ketamine prevents learning impairment when administered immediately after status epilepticus onset. Epilepsy Behav. 2 (2001) 585-591
57. Towne A.R., Garnett L.K., Waterhouse E.J., Morton L.D., and DeLorenzo R.J. The use of topiramate in refractory status epilepticus. Neurology 62 (2003) 332-334
58. Tuszynski M.H., and Gage F.H. Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4621-4625
59. Vielhaber S., Kudin A.P., Kudina T.A., Stiller D., Scheich H., Schoenfeld A., Feistner H., Heinze H.J., Elger C.E., and Kunz W.S. Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats. Eur. J. Neurosci. 18 (2003) 2292-2300
60. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res. 28 (1997) 167-179
61. Yang Y., Li Q., and Shuaib A. Enhanced neuroprotection and reduced hemorrhagic incidence in focal cerebral ischemia of rat by low dose combination therapy of urokinase and topiramate. Neuropharmacology 39 (2000) 881-888
62. Zhang X., Velumian A.A., Jones O.T., and Carlen P.L. Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate. Epilepsia 41 (2000) S52-S60
63. Zhao Q., Hu Y., and Holmes G.L. Effect of topiramate on cognitive function and activity level following neonatal seizures. Epilepsy Behav. 6 (2005) 529-536
64. Zona C., Ciotti M.T., and Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 231 (1997) 123-126